Table 3.
Distribution and adequacy of judgments in the joint blinding domain for subjective outcomes classified as subjective
| Outcome category | Reassessments of judgments in our study | Total | Inadequate | ||||
|---|---|---|---|---|---|---|---|
| Judgment by Cochrane authors | High risk | Low risk | Unclear risk | N (%) | judgments N (% total) | ||
| Clinician RRRa | 92 | 41 | 120 | 253 | (57.8%) | 111 | (59.4%) |
| High risk | 60 | 2 | 20 | 82 | (32.4%) | 22 | (11.8%) |
| Low risk | 8 | 30 | 48 | 86 | (34.0%) | 56 | (29.9%) |
| Unclear risk | 24 | 9 | 52 | 85 | (33.6%) | 33 | (17.6%) |
| Patient RRRa | 63 | 9 | 36 | 108 | (24.7%) | 46 | (24.6%) |
| High risk | 36 | 0 | 17 | 53 | (49.1%) | 17 | (9.1%) |
| Low risk | 2 | 9 | 2 | 13 | (12.0%) | 4 | (2.1%) |
| Unclear risk | 25 | 0 | 17 | 42 | (38.9%) | 25 | (13.4%) |
| Subjective | 58 | 2 | 17 | 77 | (17.6%) | 30 | (16.0%) |
| High risk | 38 | 0 | 0 | 38 | (49.4%) | 0 | (0.0%) |
| Low risk | 1 | 2 | 10 | 13 | (16.9%) | 11 | (5.9%) |
| Unclear risk | 19 | 0 | 7 | 26 | (33.8%) | 19 | (10.2%) |
| Total | 213 (48.6%) | 52 (11.9%) | 173 (39.5%) | 438 | (100%) | 187 | (42.7%) |
a RRR =—rated /—related /—reported